Due to the rapid growth in IT technology, digital data have increased availability, creating novel security threats that need immediate attention. An intrusion detection system (IDS) is the most promising solution for preventing malicious intrusions and tracing suspicious network behavioral patterns. Machine learning (ML) methods are widely used in IDS. Due to a limited training dataset, an ML-based IDS generates a higher false detection ratio and encounters data imbalance issues. To deal with the data-imbalance issue, this research develops an efficient hybrid network-based IDS model (HNIDS), which is utilized using the enhanced genetic algorithm and particle swarm optimization(EGA-PSO) and improved random forest (IRF) methods. In the initial phase, the proposed HNIDS utilizes hybrid EGA-PSO methods to enhance the minor data samples and thus produce a balanced data set to learn the sample attributes of small samples more accurately. In the proposed HNIDS, a PSO method improves the vector. GA is enhanced by adding a multi-objective function, which selects the best features and achieves improved fitness outcomes to explore the essential features and helps minimize dimensions, enhance the true positive rate (TPR), and lower the false positive rate (FPR). In the next phase, an IRF eliminates the less significant attributes, incorporates a list of decision trees across each iterative process, supervises the classifier’s performance, and prevents overfitting issues. The performance of the proposed method and existing ML methods are tested using the benchmark datasets NSL-KDD. The experimental findings demonstrated that the proposed HNIDS method achieves an accuracy of 98.979% on BCC and 88.149% on MCC for the NSL-KDD dataset, which is far better than the other ML methods i.e., SVM, RF, LR, NB, LDA, and CART.

Glaucoma is the second leading cause of loss of vision in the world. Examining the head of optic nerve (cup-to-disc ratio) is very important for diagnosing glaucoma and for patient monitoring after diagnosis. Images of optic disc and optic cup are acquired by fundus camera as well as Optical Coherence Tomography. The optic disc and optic cup segmentation techniques are used to isolate the relevant parts of the retinal image and to calculate the cup-to-disc ratio. The main objective of this paper is to review segmentation methodologies and techniques for the disc and cup boundaries which are utilized to calculate the disc and cup geometrical parameters automatically and accurately to help the professionals in the glaucoma to have a wide view and more details about the optic nerve head structure using retinal fundus images. We provide a brief description of each technique, highlighting its classification and performance metrics. The current and future research directions are summarized and discussed.

The complicated capillary network induced by angiogenesis is one of the main reasons of unsuccessful cancer therapy. A multi-scale mathematical method which simulates drug transport to a solid tumor is used in this study to investigate how capillary network structure affects drug delivery. The mathematical method involves processes such as blood flow through vessels, solute and fluid diffusion, convective transport in extracellular matrix, and extravasation from blood vessels. The effect of heterogeneous dynamic network on interstitial fluid flow and drug delivery is investigated by this multi-scale method. The sprouting angiogenesis model is used for generating capillary network and then fluid flow governing equations are implemented to calculate blood flow through the tumor-induced capillary network and fluid flow in normal and tumor tissues. Finally, convection-diffusion equation is used to simulate drug delivery. Three approaches are used to simulate drug transport based on the developed mathematical method: without a vascular network, using a static vascular network, and a dynamic vascular network. The avascular approach predicts more uniform and higher drug concentration than vascular approaches since the simplified assumptions are implemented in this method. The dynamic network which uses more realistic assumptions predicts more irregular blood vessels, high interstitial pressure, and more heterogeneity in drug distribution than other two approaches.

The computational methods provide condition for investigation related to the process of drug delivery, such as convection and diffusion of drug in extracellular matrices, drug extravasation from microvessels or to lymphatic vessels. The information of this process clarifies the mechanisms of drug delivery from the injection site to absorption by a solid tumor. In this study, an advanced numerical method is used to solve fluid flow and solute transport equations simultaneously to investigate the effect of tumor shape and size on drug delivery to solid tumor.

Industrial automation systems are undergoing a revolutionary change with the use of Internet-connected operating equipment and the adoption of cutting-edge advanced technology such as AI, IoT, cloud computing, and deep learning within business organizations. These innovative and additional solutions are facilitating Industry 4.0. However, the emergence of these technological advances and the quality solutions that they enable will also introduce unique security challenges whose consequence needs to be identified. This research presents a hybrid intrusion detection model (HIDM) that uses OCNN-LSTM and transfer learning (TL) for Industry 4.0. The proposed model utilizes an optimized CNN by using enhanced parameters of the CNN via the grey wolf optimizer (GWO) method, which fine-tunes the CNN parameters and helps to improve the model’s prediction accuracy. The transfer learning model helps to train the model, and it transfers the knowledge to the OCNN-LSTM model. The TL method enhances the training process, acquiring the necessary knowledge from the OCNN-LSTM model and utilizing it in each next cycle, which helps to improve detection accuracy. To measure the performance of the proposed model, we conducted a multi-class classification analysis on various online industrial IDS datasets, i.e., ToN-IoT and UNW-NB15. We have conducted two experiments for these two datasets, and various performance-measuring parameters, i.e., precision, F-measure, recall, accuracy, and detection rate, were calculated for the OCNN-LSTM model with and without TL and also for the CNN and LSTM models. For the ToN-IoT dataset, the OCNN-LSTM with TL model achieved a precision of 92.7%; for the UNW-NB15 dataset, the precision was 94.25%, which is higher than OCNN-LSTM without TL.

Application of drugs in high doses has been required due to the limitations of no specificity, short circulation half-lives, as well as low bioavailability and solubility. Higher toxicity is the result of high dosage administration of drug molecules that increase the side effects of the drugs. Recently, nanomedicine, that is the utilization of nanotechnology in healthcare with clinical applications, has made many advancements in the areas of cancer diagnosis and therapy. To overcome the challenge of patient-specificity as well as time- and dose-dependency of drug administration, artificial intelligence (AI) can be significantly beneficial for optimization of nanomedicine and combinatorial nanotherapy. AI has become a tool for researchers to manage complicated and big data, ranging from achieving complementary results to routine statistical analyses. AI enhances the prediction precision of treatment impact in cancer patients and specify estimation outcomes. Application of AI in nanotechnology leads to a new field of study, i.e., nanoinformatics. Besides, AI can be coupled with nanorobots, as an emerging technology, to develop targeted drug delivery systems. Furthermore, by the advancements in the nanomedicine field, AI-based combination therapy can facilitate the understanding of diagnosis and therapy of the cancer patients. The main objectives of this review are to discuss the current developments, possibilities, and future visions in naoinformatics, for providing more effective treatment for cancer patients.